Frost & Sullivan to Moderate International Conference at MEDICA 2007

Frost & SullivanHosted by the U.S. Government in partnership with Frost & Sullivan and several strategic partners, the International Conference at MEDICA 2007 is expected to see attendance by every international medical device, equipment and diagnostic company. This pioneering event offers the international medical technology community a unique opportunity to tap the expertise and resources needed to be successful on the world's most important medical market - the USA.

Dorman Followwill, Vice President, Health Care, Frost & Sullivan, who will moderate the conference, notes that this event comes at a time when international medical technology firms, facing strong cost containment pressures, slower growth and challenging regulatory environments, are looking to the U.S. as a rewarding market for innovative products.

"Clearly, the U.S. market offers medical device companies several global competitive advantages," says Followwill. "However, it is essential for international firms to implement the correct strategy on local engagement in the highly competitive U.S. market where volatile currency fluctuations, heightened scrutiny on import safety issues, complex reimbursement systems and regional/local market preferences and practices, all demand careful consideration."

Through this conference, participants will be privy to crucial information and insights aimed at helping international medtech companies establish a presence or expand in the United States. Experts from the U.S. Department of Commerce, its U.S. federal state partners, the U.S. Food and Drug Administration, along with leading industry association officials, company heads and prominent legal, financial and business advisors in the health technology sector will make presentations, participate in panel discussions.

Besides in-depth and insightful information, the forum offers attractive networking opportunities. Attendees can profit from personal consultations with expert speakers and U.S. state representatives during breaks, the relaxed networking reception and in follow on meetings.

In short, anyone responsible for a medical company's global success will find invaluable guidance and networking opportunities on November 13th at the Hilton Hotel, Düsseldorf.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...